Pravin R. Chaturvedi - Apr 5, 2022 Form 4/A - Amendment Insider Report for Jaguar Health, Inc. (JAGX)

Role: Chief Scientific Officer
Signature: /s/ Pravin R. Chaturvedi
Stock symbol: JAGX
Transactions as of: Apr 5, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 5/19/2023, 08:44 PM
Date Of Original Report: Apr 6, 2022
Previous filing: Mar 30, 2022
Next filing: Dec 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAGX	Common Stock	Options Exercise		+10K			10K	Apr 5, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JAGX	Restricted stock units	Award	$0	+10K	+100%	$0.00	20K	Apr 5, 2022	Common Stock	10K		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
F3	On April 6, 2022, the reporting person filed a Form 4 that erroneously indicated that 3,333 restricted stock units had vested on April 5, 2022 and that the reporting person beneficially owned 6,666 restricted stock units following such vesting. In fact, 10,000 restricted stock units had vested on such date and the reporting person beneficially owned 20,000 restricted stock units following such vesting.